We are moving healthcare forward
Digital therapeutics (DTx) can address critical gaps in healthcare. These solutions offer unprecedented access to safe and effective treatments through the power of technology.
We have designed an evidence-driven and milestone-based approach to DTx
discovery & development
Building a digital bridge into the clinical setting
Sidekick's DTx products complement traditional medical treatments and provide a digital bridge into the clinical setting. They give patients access to personalized treatments via smartphones and tablets, empowering them to take control of their own health.
Our platform powers the industry's broadest DTx portfolio
The major challenge facing the world’s healthcare systems is how to support and treat people with multiple lifestyle-related diseases. The cornerstone of Sidekick’s approach is our multi-chronic digital care platform, allowing us to scale the production of DTx products across all major chronic diseases.
Sidekick operates its platform in partnership with some of the biggest names in the pharmaceutical industry to augment pharmacotherapy. We develop integrated combination therapeutics consisting of a drug (Rx) and a DTx to create standalone, prescription DTx products (PDTs).
Reducing the cost of care
Our DTx products are also deployed in partnership with leading payers and healthcare providers. With a sharp focus on cost of care for the multi-chronic population, Sidekick's DTx products can help prevent serious illnesses and expensive hospital visits by enabling regular remote patient monitoring.
Because multi-chronic populations account for the majority of global healthcare costs, the benefit for payers and healthcare providers is clear.
Preventing, treating and managing this population will decrease overall costs and significantly increase the quality-adjusted life years (QALYs) of those affected.